A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.
John Bobiak
Advertisement
John Bobiak, PhD, is with Bristol-Myers Squibb
Articles by John Bobiak
A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.
Advertisement
Latest Updated Articles
- AAPS Workshop Summary
Published: November 2nd 2012 | Updated:
- Pharmaceutical Stability: Scientific and Regulatory Considerations for Global Drug Development and Commercialization
Published: November 3rd 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
2
Everything to Know About Pharmaceutical Tariffs in 2025
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
